 |
|
|
| |
Persistence of NS5A Drug Resistance Mutations Following 3 Days of GS-5885 Monotherapy in Genotype-1 HCV Patients is Dependent on the HCV Subtype and Specific Mutation
|
| |
| |
Reported by Jules Levin
EASL 2012 Apr 18-22 Barcelona Spain
KA Wong1, A Worth1, DM Brainard1, E Lawitz2, MD Miller1, H Mo1
1Gilead Sciences, Inc., Foster City, CA, USA, 2Alamo Medical Research, San Antonio, TX, USA
|
| |
|
|
|
|
|
